Results 251 to 260 of about 106,495 (306)

TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn²⁺ Homeostasis. [PDF]

Circulation
Li X, Li X, Li CX, Feng J, Yue Z, Yan J, Matsushita M, Qyang Y, Runnels LW, Ai X, Yue L.   +10 more
europepmc   +1 more source

Histone Modifications in Cardiovascular Disease: Mechanisms and Therapeutic Opportunities

MedComm, Volume 7, Issue 5, May 2026.
This graphical abstract summarizes how classical and emerging histone posttranslational modifications (PTMs), together with their chromatin regulators (writers, erasers, and readers), govern major pathobiological programs in cardiovascular disease.
Yu Zheng, Yu‐Xuan Gao, Mei‐Xing Guo, Li‐Ting Wang, Xiao‐Wen Zheng, Yi‐Hao Liao, Ya Li, Jun‐Ping Zhu, Jia‐Ming Wei   +8 more
wiley   +1 more source

LncRNA KCNQ1OT1 aggravates myocardial ischemia/reperfusion injury by mediating the EZH2/TIMP-3 axis. [PDF]

Korean J Physiol Pharmacol
Xing Z, Shajidan A, Palida A, Wang Y, Lv M, Gao Y.   +5 more
europepmc   +1 more source

Amentoflavone, a Preferentially TGF‐β Receptor 1 Inhibitor, Alleviates Cardiac Remodeling and Dysfunction Through Modulating the TGF‐β/Smad and MAPK Signaling Pathways

Phytotherapy Research, Volume 40, Issue 5, Page 2380-2396, May 2026.
Amentoflavone, a preferentially TGF‐ββ receptor 1 inhibitor, attenuates transverse aortic constriction (TAC)‐triggered cardiac hypertrophy, fibrosis, and dysfunction by suppressing downstream Smad and MAPK signaling cascades in cardiomyocytes and cardiac fibroblasts.
Jiangjiao Wu, Chengcheng Zhao, Xiaoping Li, Xinyi Guo, Wenjie Tan, Lu Zhou, Ye Zhang, Jianli Zhang, Shuo Zheng, Chunyu Zeng, Gengze Wu   +10 more
wiley   +1 more source

Prussian blue nanoparticles targeting multiple PANoptosome-mediated PANoptosis for myocardial ischemia-reperfusion injury therapy. [PDF]

Nat Commun
Xu L, Jiang L, Wu R, Yan H, Li B, Cai X, Zheng Y.   +6 more
europepmc   +1 more source

Remote Activation of Spinal TRPV1 by Magnetic Nanocubes Confers Cardioprotection Against Myocardial Ischemia-Reperfusion Injury. [PDF]

Adv Sci (Weinh)
Cheng X, Liu S, Zhang Y, Peng K, Qile M, Wu C, Dou M, Liu L, Yang N, Liu R, Zhang G, Ni L, Liang G, Yang F, Zhang Y, He S.   +15 more
europepmc   +1 more source

Identification of NF-κB pathway-related biomarkers in myocardial ischemia-reperfusion injury: based on transcriptomics analysis and RT-qPCR validation. [PDF]

Sci Rep
Ting W, Helong X, Xiaoyu W, Chuanqiang W, Xiao H, Yang Y, Zhe Y, Shaopeng X, Xiaoyong G.   +8 more
europepmc   +1 more source

Estrogen Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. [PDF]

Cardiol Res Pract
Cheng J, Li Y, Shen S, Sheng J, Xu B, Wang X, Cheng C, He F.   +7 more
europepmc   +1 more source

Myocardial ischemia-reperfusion injury after acute myocardial infarction: spatiotemporal mechanisms and endotype-matched multi-target modulation by compounds from traditional Chinese medicine. [PDF]

Front Cardiovasc Med
Sun L, Guan R, Gao M, Gu Z, Zhang M.
europepmc   +1 more source